Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ambispective Observational Study on Retention in Care and on Clinical Chracteristics of HIV-infected Women Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIKWO).

NCT07859904 is registered in ClinicalTrials.gov with Ente Ospedaliero Ospedali Galliera as lead sponsor.

NCT NCT07859904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07859904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ambispective Observational Study on Retention in Care and on Clinical Chracteristics of HIV-infected Women Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIKWO).
Lead sponsor
Ente Ospedaliero Ospedali Galliera
Phase
Observational
Overall status
Not yet recruiting
Start date
December 15, 2026
Completion date
January 31, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv 1 infection